Approvals· August 30, 2026 · 16 min read
Mounjaro's CV Claim Is Noninferiority vs Trulicity, Not Placebo Superiority
By Ran Chen#GLP-1#GIP/GLP-1#Diabetes and Obesity
Topic
Eli Lilly
Eli Lilly and Company pipeline, M&A strategy, neurodegeneration and psychiatric acquisitions, and commercial launches.
Deals· August 5, 2026 · 19 min read
Lilly's $3.8B AtaiBeckley deal: big pharma validates psychedelics for TRD
By Ran Chen#M&A#Eli Lilly#Psychedelic Therapy
Pipeline· July 28, 2026 · 25 min read